Menu
×
×

Sign Up

Your Profile will be reviewed by Admin
TODAY :
EVENT DATE
Oct 2017
MoTuWeThFrSaSu
      1
2345678
9101112131415
16171819202122
23242526272829
3031     
EXPO DATE
Oct 2017
MoTuWeThFrSaSu
      1
2345678
9101112131415
16171819202122
23242526272829
3031     

Venue

Sheraton Boston Hotel 39 Dalton Street Boston , Massachusetts 02199
Tel: (617) 236-2000
Website
Google Map

12th Annual Cardiometabolic Health Congress (CMHC)

1,400 0

Overview

Event Overview:

Integrated management of all aspects of cardiometabolic risk is the only way to approach the rapidly growing epidemic of cardiovascular and metabolic disease. The Cardiometabolic Health Congress provides a one-of-a-kind opportunity to stay informed on the latest scientific and clinical developments in these overlapping disease areas through a comprehensive and integrated agenda.

The CMHC has grown to be the largest multidisciplinary conference addressing the prevention, diagnosis, and management of cardiometabolic diseases in the US.

CMHC offers new educational formats, 27+ credit hours, symposia and workshops, lively debates with ample time for Q&A, renowned faculty and Meet-the-Expert sessions, and an expanded exhibit hall showcasing technological innovations, products, and prevention tools to improve your practice.

Whether you're new to CMHC, or one of the many clinicians who has joined us in past years, please Register Today.

Exhibitor Information:

An exhibit booth is an investment as well as an engagement-and one that should begin reaping rewards the moment you submit your application. CMHC offers opportunities to engage with hundreds of leading clinicians and thought leaders before, during and after the Congress through our multimedia channels.

Who Should Exhibit?
Any company that wants to reach motivated, frontline clinicians involved in cardiometabolic risk management. CMHC attendees are diverse and multidisciplinary, yet they all share the desire for knowledge about the most useful products and services to improve patient outcomes.

Benefits & Enhanced Exposure in 2017!

Extensive promotion of exhibiting companies through multiple channels including CMHC program brochure mailings, email and social media campaigns, a listing and description in the conference guide, hyperlinks on the CMHC website and the CMHC App.
Individualized marketing support, with optional promotional opportunities to drive attendees to your booth!
Meet the Faculty Lounge in Exhibit Hall - Attendee Favorite!

Agenda

Oct 4   

10:00 am - 11:00 am

Pre-Con BoM Session
Patient-Centered Medical Home A Foundation for Transformation
Paul Grundy, MD

11:00 am - 12:00 pm

NON-CME Session
The Cardiometabolic Implications of Obesity and Nutritional Strategies for Prevention
Frank B. Hu, MD, PhD
Sponsored by Metagenics, Inc.

12:00 pm - 1:15 pm

NON-CME Session (Lunch)
Repatha®(evolocumab): Take the Next Step
Yehuda Handelsman, MD
Sponsored by Amgen, Inc.

1:20 - 2:20 pm

Pre-Con BoM Session
Best Practices: Efficient and Cost Effective Management of the Authorization Process
Pamela B. Morris, MD
Kim K. Birtcher, PharmD
Supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals.

2:30 - 3:20 pm

Pre-Con BoM Session
Expert Discussion: The Psychology Behind Patient Adherence
Robert H. Eckel, MD
William H. Polonsky, PhD, CDE

3:30 - 4:45 pm

Pre-Con BoM Featured Session
How to Grow Your Revenue By Enhancing Your Presence: In Person & On Camera
Mark J. Tager, MD
Robert John Hughes

5:00 - 6:00 pm

NON-CME Session (Light Bites)
Awaken a Transformation in Type 2 Diabetes Management
Yehuda Handelsman, MD
Sponsored by Janssen Pharmaceuticals, Inc.

6:00 - 7:00 pm

NON-CME Session (Light Bites)
Advancements in the Management of Patients With Type 2 Diabetes: Results From a Large Cardiovascular Outcomes Trial
Michael H. Davidson, MD
Sponsored by Novo Nordisk.

7:00 - 8:00 pm

NON-CME Session (Dinner)
JARDIANCE® (empagliflozin) Tablets: Evolving Clinical Development
Rajat Deo, MD
Sponsored by Boehringer-Ingelheim Pharmaceuticals, Inc./Lilly USA

Oct 5   

6:40 - 7:55 am

 

CME Breakfast Symposium
Closing the Gap Created by Clinical Inertia: New Strategies for T2DM Treatment

Chair:Robert H. Eckel, MD

Presenters:Julio Rosenstock, MD
Athena Philis-Tsimikas, MD
Yehuda Handelsman, MD

Supported by an educational grant from Sanofi US.

Session I: Dyslipidemia, Atherosclerosis and Cardiovascular Disease Risk Reduction

8:00 - 8:05 am

Opening Remarks
Christie M. Ballantyne, MD

8:05 - 9:20 am

FDA Update and Late Breaking Clinical Trials

Chair:Christie M. Ballantyne, MD

Panelists:Robert H. Eckel, MD
Jay S. Skyler, MD
Keith C. Ferdinand, MD
Deepak L. Bhatt, MD, MPH

9:20 - 10:20 am

Attacking Atherothrombosis: Which Approach to Take?

Chair:Christie M. Ballantyne, MD

Presenters:Paul M. Ridker, MD
Eugene Braunwald, MD
Marc S. Sabatine, MD

10:20 - 11:20 am

Morning Break - Exhibit Hall

11:20 am - 12:10 pm

MAIN KEYNOTE:
Gut Microbes as a Participant and Therapeutic Target in Cardiometabolic Diseases

Stanley L. Hazen, MD, PhD

12:15 - 1:15 pm

CME Lunch Symposium
Navigating Updated Guidelines and New Therapies for the Diagnosis and Treatment of Heart Failure

Chair:Keith C. Ferdinand, MD

Presenters:Clyde W. Yancy, MD
JoAnn Lindenfeld, MD

Supported in part by an educational grant from Novartis Pharmaceuticals Corporation.

1:20 - 2:00 pm

Mini Session
Lp(a) and Promising NEW Targets for Intervention

Sotirios Tsimikas, MD

2:00 - 2:30 pm

Mini Featured Session
Treatment for Statin Intolerant Patients with Hypercholesterolemia – Today and Tomorrow

This session is supported by an educational grant from Esperion.

2:30 - 3:30 pm

Afternoon Break - Exhibit Hall

3:30 - 4:10 pm

FEATURED SESSION
Topic: Triglycerides and HDL-C: Where Are We Now?

Robert H. Eckel, MD

4:10 - 5:00 pm

Multidisciplinary Case Consults: Challenging Lipid Cases

Chair:Christie M. Ballantyne, MD

Panelists:Robert H. Eckel, MD
Jay S. Skyler, MD
Kim K. Birtcher, PharmD

5:00 pm

Closing Remarks
Christie M. Ballantyne, MD

5:00 - 6:00 pm

Welcome Reception - Exhibit Hall
Christie M. Ballantyne, MD
George L. Bakris, MD
Robert H. Eckel, MD
Jay S. Skyler, MD

6:00 - 7:00 pm

NON-CME Session (Dinner)
Clinical Evaluation of Pure EP
Matthew J. Budoff, MD
Sponsored by Amarin Pharmaceuticals, Inc.

7:00 - 8:30 pm

CME Dinner Symposia

Oct 6   

6:45 - 7:45 am

CME Breakfast Symposium
Interventional Cardiology Delivered With a Fork

Stephen Devries, MD
Supported by educational funding from Tarsus Cardio Inc. dba Cardiometabolic Health Congress.

Session II: Lifestyle Management of Cardiovascular Disease

8:00 - 8:05 am

Opening Remarks
Robert H. Eckel, MD

8:05 - 8:55 am

FEATURED SESSION
Topic: Novel Mechanisms for the Link Between Obesity and Type 2 Diabetes

Barbara Kahn, MD

8:55 - 9:45 am

Cardiometabolic Disorders: Diet Quality, Quantity and Beyond

Chair:Robert H. Eckel, MD

Presenters:Jamy Ard, MD
Janet M. de Jesus, MS, RD
John P. Foreyt, PhD

9:45 - 10:45 am

Morning Break - Exhibit Hall

10:55 - 11:25 am

Mini Session: Sleep Science: Effect of the Circadian Rhythm on Obesity and CVD
Frank A.J.L. Scheer, PhD

11:25 am - 12:15 pm

Multidisciplinary Case Consults: Lifestyle and Obesity Management in the Cardiometabolic Patient

Chair:Robert H. Eckel, MD

Panelists:George L. Bakris, MD
Christie M. Ballantyne, MD
Jay S. Skyler, MD
Janet M. de Jesus, MS, RD
Johannes Scholl, MD

12:25 - 1:40 pm

CME Lunch Symposium
CV Protection: Is It Achievable in Patients With T2DM?

Chair:Jay S. Skyler, MD

Presenters:Wendy S. Lane, MD
Robert H. Eckel, MD
Benjamin M. Scirica, MD, MPH

Multi-supported by educational grants from Novo Nordisk, Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

Session III: Diabetes Management

1:40 - 1:45 pm

Opening Remarks
Jay S. Skyler, MD

1:45 - 2:25 pm

FEATURED SESSION
Topic: New Insights Into Insulin Resistance and How the Body Responds to It

C. Ronald Kahn, MD

2:25 - 3:00 pm

Reaching Glycemic Goals for Patients with T2DM: Insulin and Non-Insulin Therapies
Anne L. Peters, MD

3:00 - 4:00 pm

Afternoon Break - Exhibit Hall

4:00 - 5:15 pm

Managing Microvascular Complications of Diabetes for Improved Patient Outcomes

Chair:Jay S. Skyler, MD

Presenters:Thomas Gardner, MD
George L. Bakris, MD
Roy L. Freeman, MD

5:15 - 5:55 pm

Multidisciplinary Case Consults: Challenging T2DM Patient Cases

Chair:Jay S. Skyler, MD

Panelists:Robert H. Eckel, MD
George L. Bakris, MD
Christie M. Ballantyne, MD
Davida Kruger, MSN, APN-BC, BC-ADM

5:55 - 6:00 pm

Closing Remarks
Jay S. Skyler, MD

6:00 - 7:00 pm

Closing Reception - Exhibit Hall

7:00 - 8:15 pm

NON-CME Session (Dinner)
Hypertriglyceridemia & Pancreatitis: Separating Secondary Causes from Familial Chylomicronemia Syndrome (FCS)
Paul D. Rosenblit, MD, PHD, FACE, FNLA
Sponsored by Akcea Therapeutics

Oct 7   

6:45 - 7:45 am

CME Breakfast Symposium
Hyperkalemia Management and Monitoring in High-Risk Patients: Improving Heart d Failure Management an Outcomes

Chair:George L. Bakris, MD

Presenters:JoAnn Lindenfeld, MD

Supported in part by an educational grant from Relypsa, Inc.

Session IV: Hypertension, Cardio-renal, Heart Failure

8:00 - 8:05 am

Opening Remarks
George L. Bakris, MD

8:05 - 8:55 am

FEATURED SESSION
Topic: Metabolomics and Kidney Disease

Kumar Sharma, MD

8:55 - 9:25 am

2017 Guideline Updates: Blood Pressure and Resistant Hypertension
David A. Calhoun, MD

9:25 - 9:55 am

Morning Break - Grand Ballroom Foyer

9:55 - 11:05 am

Integrative Topics in Blood Pressure and Hypertension Management

Chair:George L. Bakris, MD

Presenters:Kumar Sharma, MD
Virend Somers, MD
David G. Harrison, MD

11:05 - 11:55 am

Multidisciplinary Case Consults: Challenging Patient Cases in Hypertension, Cardio-Renal, and Heart Failure

Chair:George L. Bakris, MD

Panelists:Robert H. Eckel, MD
Christie M. Ballantyne, MD
Keith C. Ferdinand, MD
Kumar Sharma, MD
David A. Calhoun, MD

11:55 am - 12:25 pm

Mini Session: Kidney Disease in the Elderly
George L. Bakris, MD

12:25 - 12:30 pm

Closing Remarks
George L. Bakris, MD

Keynote Speakers

Stanley L. Hazen

Chair, Department of Cellular & Molecular Medicine, Vice Chair, Translational Research, Lerner Research Institute Section Head, Preventive Cardiology & Rehabilitation Director, Center for Cardiovascular Diagnostics & Prevention Cleveland Clinic Cleveland, OH

Stanley Hazen, MD, PhD, is the Head of the Section for Preventive Cardiology and Rehabilitation, Vice Chair of Translational Research, Lerner Research Institute, Director for the Center for Cardiovascular Diagnostics and Prevention, Director of the Cleveland Clinic Mass Spectrometry Core Facilities, Department Chair in the Department of Cell Biology and Section Head in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic.

Dr. Hazen is board-certified as a Diplomat of the American Board of Internal Medicine. He has also completed subspecialty training in endocrinology, diabetes and metabolism. He sees patients within the Preventive Cardiology Clinic, specializing in preventive cardiovascular medicine care of patients including treatment of hyperlipidemia, diabetes, hypertension, obesity. He also sees patients within the Cardiovascular Rehabilitation program. His research interests include understanding the role of inflammation and oxidant stress in the pathogenesis of atherosclerosis and other inflammatory diseases. He is an expert in mechanisms of atherosclerosis, HDL structure and metabolism, the biochemistry of leukocyte peroxidases, free radicals and reactive oxygen species and mechanisms of oxidative damage.

Dr. Hazen has published over 200 peer-reviewed articles, invited reviews and book chapters in the fields of atherosclerosis, oxidation and inflammation chemistry, and cardiovascular disease. He has received many honors and awards for his research work, which has contributed to new understandings of inflammation in cardiovascular disease and the development of new diagnostic and treatment tools. He is listed as a co-inventor on multiple patents for his work in identifying patients at increased risk for cardiovascular disease, diagnosing asthma, and treating inflammation and associated complications. He has been principal investigator on numerous National Institutes of Health grants and research awards related to his specialty interests.

He serves as reviewer for more than 20 scientific journals including Circulation, Analytical Biochemistry, Journal of Clinical Investigation, Journal of Biological Chemistry and the Journal of Lipid Research. Dr. Hazen is Associate Editor of the Journal of Lipid Research, and serves on the editorial board of Circulation, The Journal of Biological Chemistry and Free Radicals in Biology & Medicine. He has been invited to lecture at national and international symposia and conferences in both basic science and clinical fields alike, as well as workshops held by the National Academy of Science, and National Heart, Lung and Blood Institutes (National Institutes of Health) on Emerging Science for Environmental Health Decisions, mechanisms of atherogenesis, pulmonary immunobiology and inflammation, the origins of asthma, and nitric oxide biology.

Dr. Hazen has received numerous awards including election to membership in honorary societies in science and clinical arenas alike including the American Society for Clinical Investigation (ASCI) and the American Association of Physicians (AAP). He also is an elected fellow of the American Association for the Advancement of Science (AAAS). He holds memberships to the American College of Physicians, the American Federation for Medical Research, the American Heart Association Scientific Council for Arteriosclerosis, the American Medical Association, the American Society for Mass Spectrometry, the International Society for Free Radical Research, the Society for Free Radical Biology & Medicine, and the American Society for Investigative Pathology.

Press Releases +

Photos +

Videos +

RELATED EVENTS +

MORE events +

Display Makers +